Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration this week released two guidances outlining regulatory frameworks for sponsors developing molecularly-informed oncology therapies.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.